BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 32571328)

  • 41. microRNA-130a Promotes Human Keratinocyte Viability and Migration and Inhibits Apoptosis Through Direct Regulation of STK40-Mediated NF-κB Pathway and Indirect Regulation of SOX9-Meditated JNK/MAPK Pathway: A Potential Role in Psoriasis.
    Xiong Y; Chen H; Liu L; Lu L; Wang Z; Tian F; Zhao Y
    DNA Cell Biol; 2017 Mar; 36(3):219-226. PubMed ID: 28085489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
    Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
    Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2.
    Li G; Wu F; Yang H; Deng X; Yuan Y
    Biomed Pharmacother; 2017 Dec; 96():1170-1178. PubMed ID: 29239816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-142-5p Suppresses Lung Cancer Cell Metastasis by Targeting Yin Yang 1 to Regulate Epithelial-Mesenchymal Transition.
    Zhang Q; Liu H; Zhang J; Shan L; Yibureyimu B; Nurlan A; Aerxiding P; Luo Q
    Cell Reprogram; 2020 Dec; 22(6):328-336. PubMed ID: 33270501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MicroRNA-130a enhances the killing ability of natural killer cells against non-small cell lung cancer cells by targeting signal transducers and activators of transcription 3.
    Zhou X; Liu S; Liu J; Zhang Z; Mao X; Zhou H
    Biochem Biophys Res Commun; 2020 Mar; 523(2):481-486. PubMed ID: 31883616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-183 Acts as a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Down-Regulating MTA1.
    Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
    Cell Physiol Biochem; 2018; 46(1):93-106. PubMed ID: 29587281
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling.
    Su C; Han Y; Zhang H; Li Y; Yi L; Wang X; Zhou S; Yu D; Song X; Xiao N; Cao X; Liu Z
    J Cell Mol Med; 2018 Jun; 22(6):3097-3107. PubMed ID: 29532994
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
    Wang H; Wang L; Zhang S; Xu Z; Zhang G
    Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TNFAIP2 Promotes Non-Small Cell Lung Cancer Cells and Targeted by miR-145-5p.
    Li J; Song Y; Yu B; Yu Y
    DNA Cell Biol; 2020 Jul; 39(7):1256-1263. PubMed ID: 32456459
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stromal-derived miR-486-5p promotes metastasis of non-small-cell lung cancer cells by targeting the CADM1/tight junctions axis in vascular endothelial cells.
    Sun B; Han Y; Shi M
    Cell Biol Int; 2021 Apr; 45(4):849-857. PubMed ID: 33325094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinesin family member 3C (KIF3C) is a novel non-small cell lung cancer (NSCLC) oncogene whose expression is modulated by microRNA-150-5p (miR-150-5p) and microRNA-186-3p (miR-186-3p).
    Liu H; Liu R; Hao M; Zhao X; Li C
    Bioengineered; 2021 Dec; 12(1):3077-3088. PubMed ID: 34193018
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer.
    Zhang JX; Zhai JF; Yang XT; Wang J
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3793-3801. PubMed ID: 27735039
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of miR-6884-5p in epithelial-mesenchymal transition in non-small cell lung cancer.
    Zhang L; Chi W; Wang X; Li J; Li F; Ma Y; Zhang Q
    Aging (Albany NY); 2024 Jan; 16(2):1968-1979. PubMed ID: 38271114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Tumor Suppressive Role of MiRNA-509-5p by Targeting FOXM1 in Non-Small Cell Lung Cancer.
    Ma N; Zhang W; Qiao C; Luo H; Zhang X; Liu D; Zang S; Zhang L; Bai J
    Cell Physiol Biochem; 2016; 38(4):1435-46. PubMed ID: 27035590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LncRNA CCAT1/miR-130a-3p axis increases cisplatin resistance in non-small-cell lung cancer cell line by targeting SOX4.
    Hu B; Zhang H; Wang Z; Zhang F; Wei H; Li L
    Cancer Biol Ther; 2017 Dec; 18(12):974-983. PubMed ID: 29020498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EVI5 is an oncogene that regulates the proliferation and metastasis of NSCLC cells.
    Cai T; Zhou J; Zeng Y; Du W; Zhang Y; Liu T; Fu Y; Huang JA; Qian Q; Zhu J; Ling C; Liu Z
    J Exp Clin Cancer Res; 2020 May; 39(1):84. PubMed ID: 32393392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.